Renub Research, a leading market research and consulting company, projects that the United States Diabetes Device Market will surge from US$ 8.67 billion in 2023 to US$ 16.25 billion by 2032, growing at a CAGR of 7.23% between 2024 and 2032. This significant growth is driven by the aging population, rising diabetes prevalence due to lifestyle changes, increasing obesity rates, and the high costs of diabetes-related healthcare.

To access the full report, visit: United States Diabetes Device Market Report.


Rising Diabetes Prevalence in the United States

According to the CDC (Centers for Disease Control and Prevention), over 37 million Americans have diabetes, and millions more are prediabetic. The surge in diabetes cases is closely linked to lifestyle factors such as sedentary behavior, poor dietary habits, and rising obesity rates. This growing burden is fueling demand for advanced diabetes devices, such as insulin pumps, continuous glucose monitoring (CGM) systems, and smart insulin pens.


Technological Advancements and AI Integration

The adoption of artificial intelligence (AI) and data analytics in diabetes care is revolutionizing the industry. Modern devices now leverage AI to predict blood glucose fluctuations, provide personalized insulin dosing, and track patient health patterns. Smart wearable devices like CGM systems are gaining popularity due to their real-time monitoring capabilities and integration with smartphones.


Market Growth Drivers

  1. Aging Population: Seniors are at a higher risk for Type 2 diabetes, and the aging population in the U.S. is expanding rapidly.

  2. Rising Obesity Rates: According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), obesity is one of the leading contributors to diabetes prevalence.

  3. Healthcare Costs: The growing financial burden of managing diabetes is encouraging healthcare providers to invest in cost-effective and preventive technologies.

  4. Government Support: Initiatives to improve diabetes awareness and early detection programs are supporting market growth.


Segmentation of the United States Diabetes Device Market

By Product Type:

  • Insulin pumps

  • Continuous glucose monitoring (CGM) systems

  • Blood glucose meters

  • Smart insulin pens

  • Test strips and lancets

By End-User:

  • Hospitals and clinics

  • Homecare settings

  • Diagnostic centers

By Technology:

  • Artificial intelligence-based devices

  • Wearable smart devices

  • Cloud-connected platforms


Competitive Landscape

Leading players in the U.S. diabetes device market include Medtronic, Abbott Laboratories, Dexcom, Insulet Corporation, Roche Diabetes Care, Tandem Diabetes Care, and Novo Nordisk. These companies are investing heavily in AI-driven solutions and next-generation wearables to improve diabetes management.


Key Trends Reshaping the Market

Smart Device Integration

The integration of diabetes management apps with smart wearables (like Apple HealthKit) is enhancing patient engagement.

Personalized Diabetes Care

AI-enabled devices can provide customized treatment recommendations, improving outcomes for patients with Type 1 and Type 2 diabetes.

Focus on Preventive Healthcare

Continuous glucose monitoring is enabling proactive diabetes management, reducing the risk of severe complications.


Industry Expert Insights

“With advancements in AI and real-time glucose tracking, diabetes care in the U.S. is undergoing a transformation. The market’s projected CAGR of 7.23% reflects both innovation and the urgent need to address the rising diabetes epidemic,” said Rajat Gupta, Marketing Manager at Renub Research.


10 Frequently Asked Questions (FAQs)

1. What is the current size of the United States Diabetes Device Market?

  • The market was valued at US$ 8.67 billion in 2023.

2. What is the projected size of the market by 2032?

  • It is expected to reach US$ 16.25 billion by 2032.

3. What is the growth rate of the market?

  • The market will grow at a CAGR of 7.23% from 2024 to 2032.

4. What factors are driving this market growth?

  • Aging population, obesity, lifestyle changes, and AI-driven devices are key drivers.

5. Which devices are most popular in the U.S. diabetes market?

  • Continuous glucose monitoring (CGM) systems and insulin pumps dominate.

6. How is AI impacting diabetes devices?

  • AI provides predictive analysis, personalized care, and real-time insights for patients and healthcare providers.

7. What challenges does the market face?

  • High costs of advanced devices and reimbursement challenges remain major concerns.

8. Who are the leading players in this market?

  • Medtronic, Abbott, Dexcom, and Roche Diabetes Care lead the market.

9. What role do wearable devices play?

  • Wearables allow 24/7 glucose tracking, improving convenience and reducing the need for manual testing.

10. Where can I access detailed market insights?


About Renub Research

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, specializing in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that empower companies to make better strategic decisions.

We collaborate with clients across various industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.

Our team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Biotechnology, Medicine, Information Technology, Environmental Science, and more.

New Publish Report:


Media Contact

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com


Final Word

The United States Diabetes Device Market is poised for robust growth, fueled by advanced technology, increasing healthcare demands, and a pressing need to manage diabetes effectively. Renub Research’s detailed analysis offers a roadmap for stakeholders to seize growth opportunities and stay ahead in this evolving market.

Categorized in:

Business,

Last Update: July 18, 2025